US 9018170
Reduced volume formulation of glatiramer acetate and methods of administration
granted A61KA61K38/02A61K38/16
Quick answer
US patent 9018170 (Reduced volume formulation of glatiramer acetate and methods of administration) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/02, A61K38/16, A61K9/0019, A61P